GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells to create improved immunotherapy of cancer and other serious diseases. The company plans to exploit unique properties of tissue resident γδ T cells for effective immunotherapy.
QuellTX
5 followers
The Health Foundation
1 follower
ORCHA
1 follower
Unobravo | Telehealth & psychology service
5 followers
Sutro Biopharma
3 followers
FUJIFILM Diosynth Biotechnologies
27 followers
Active Motif
3 followers
Altera Digital Health
3 followers
Abbott
419 followers
Merck
315 followers
Dyno Therapeutics
4 followers